Similarly, based on the potency of eNOS transfection in porcine models of myocardial infarction,116 the ENACT-AMI trial (NCT00936819)117,118 was developed to evaluate the potential of eNOS transfected EPCs to ameliorate cardiac function following myocardial infarction. This evidence concerns the gene NOS3 and myocardial infarction.